This ADC product is composed of an anti-CD22 antibody (clone CR011) conjuagated via a vc linker to MMAE (CR011-vc-MMAE). It has demonstrated a response in hematological malignancies, prostate cancer treatment by a MOA (Mechanism of Action) of Depolymerize Microtubules.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-183-F(E) | Anti-Human CD22 Recombinant Antibody (Moxetumomab Pasudotox) | FuncS, IF, Neut, ELISA, FC, IP, ICC | Fv - disulfide stabilized |
TAB-1714CL | Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) | ELISA, WB | Mouse IgG |
TAB-1728CL | Anti-Human CD22 Recombinant Antibody (RFB4) | IF, FC | |
TAB-003LC-S(P) | Mouse Anti-Human CD22 Recombinant Antibody scFv Fragment | FC | |
TAB-004LC-S(P) | Anti-Human CD22 Recombinant Antibody scFv Fragment | FC |
There are currently no Customer reviews or questions for ADC-L028. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.